In a clinical trial study, patients with NAFLD showed reduction in serum ALT and AST levels after meal replacement therapy with a commercial soy yogurt honey product for 24 weeks46. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.